222 related articles for article (PubMed ID: 7006209)
1. [Malignant neoplasms after organ transplantation].
Mol'kov IuN; Golikova SD; Balakirev EM
Vopr Onkol; 1980; 26(11):107-13. PubMed ID: 7006209
[No Abstract] [Full Text] [Related]
2. Development of cancer in transplantation patients.
Penn I
Adv Surg; 1978; 12():155-91. PubMed ID: 367121
[No Abstract] [Full Text] [Related]
3. Another look at immunologic surveillance.
Schwartz RS
N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
[No Abstract] [Full Text] [Related]
4. Cancer is a complication of severe immunosuppression.
Penn I
Surg Gynecol Obstet; 1986 Jun; 162(6):603-10. PubMed ID: 3520906
[TBL] [Abstract][Full Text] [Related]
5. The occurrence of malignant tumors in immunosuppressed states.
Penn I
Prog Allergy; 1986; 37():259-300. PubMed ID: 3515352
[No Abstract] [Full Text] [Related]
6. [How great is the risk of malignancy from immunosuppressives?].
Sodomann CP; Gropp C
Internist (Berl); 1979 Dec; 20(12):571-84. PubMed ID: 398353
[No Abstract] [Full Text] [Related]
7. [Significance of immunosuppression for the origin and growth of malignant tumors].
Reis HE
Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
[No Abstract] [Full Text] [Related]
8. [Development of lymphoma and leukemia in patients receiving immunosuppressive drugs].
Rupniewska ZM; Kurowska M
Pol Tyg Lek; 1980 Mar; 35(11):411-4. PubMed ID: 6992123
[No Abstract] [Full Text] [Related]
9. [Malignomas after transplantation of thoracic organs].
Stempfle HU
Dtsch Med Wochenschr; 1998 Jan; 123(1-2):26-9. PubMed ID: 9465853
[No Abstract] [Full Text] [Related]
10. Tumors of the immunocompromised patient.
Penn I
Annu Rev Med; 1988; 39():63-73. PubMed ID: 3285791
[TBL] [Abstract][Full Text] [Related]
11. Predictive oncology. 3.
Bierman HR
Int Surg; 1973; 58(11):768-73. PubMed ID: 4584400
[No Abstract] [Full Text] [Related]
12. Tumor incidence in human allograft recipients.
Penn I
Transplant Proc; 1979 Mar; 11(1):1047-51. PubMed ID: 377608
[No Abstract] [Full Text] [Related]
13. Cancer in the immunosuppressed organ recipient.
Penn I
Transplant Proc; 1991 Apr; 23(2):1771-2. PubMed ID: 2053149
[No Abstract] [Full Text] [Related]
14. Development of cancer as a complication of clinical transplantation.
Penn I
Transplant Proc; 1977 Mar; 9(1):1121-7. PubMed ID: 325738
[No Abstract] [Full Text] [Related]
15. Malignancies associated with immunosuppressive or cytotoxic therapy.
Penn I
Surgery; 1978 May; 83(5):492-502. PubMed ID: 347611
[No Abstract] [Full Text] [Related]
16. [Immunosuppression, genesis and growth of malignant tumours].
Reis HE
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(1):42-50. PubMed ID: 4264377
[No Abstract] [Full Text] [Related]
17. Immunodeficiency and the pathogenesis of lymphoma and leukemia.
Louie S; Schwartz RS
Semin Hematol; 1978 Apr; 15(2):117-38. PubMed ID: 349695
[No Abstract] [Full Text] [Related]
18. Immunosurveillance and cancer: epidemiologic observations.
Fraumeni JF; Hoover R
Natl Cancer Inst Monogr; 1977 Dec; 47():121-6. PubMed ID: 349400
[TBL] [Abstract][Full Text] [Related]
19. Malignant disease in immunodeficient states in man.
Penn I
Recent Results Cancer Res; 1975; (52):96-106. PubMed ID: 796918
[No Abstract] [Full Text] [Related]
20. Depressed immunity and the development of cancer.
Penn I
Cancer Detect Prev; 1994; 18(4):241-52. PubMed ID: 7982234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
